COVID variants throw J&J vaccine a curveball, lowering efficacy to 66% - Ars Technica
- COVID variants throw J&J vaccine a curveball, lowering efficacy to 66% Ars Technica
- Johnson & Johnson 1-dose shot prevents COVID-19, but less than some others WGN TV Chicago
- Call for vaccination sites in disadvantaged communities WCVB Channel 5 Boston
- J&J vaccine adds to COVID-19 armoury, includes South African variant Reuters
- Unused COVID Vaccine Doses Won't Be Wasted With Rapid On-Call List CBS Denver
- View Full Coverage on Google News